FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
This article was originally published in The Tan Sheet
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.
You may also be interested in...
FDA Deputy Commissioner for Operations Michael Friedman, MD, is leaving the agency to join Monsanto's Searle division as senior VP-clinical affairs.
FDA Interim Chief Scientist and National Center for Toxicology Research Director Bernard Schwetz, PhD, may play a more prominent role at FDA under Commissioner Jane Henney, MD.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC